Computational screening
Sequence descriptors and recorded computational outputs help organise research candidates for further investigation. Prediction provenance is considered independently.

BiotaSift / Research
Explore the computational research framework behind BiotaSift: how we investigate peptide candidates, assess uncertainty and develop questions for experimental validation.
Our approach
Each step distinguishes a computational observation from an experimental conclusion.
Sequence descriptors and recorded computational outputs help organise research candidates for further investigation. Prediction provenance is considered independently.
Source documentation, reference comparisons and gaps are reviewed separately. Incomplete information is never treated as confirmation.
Research candidates can be prioritised for laboratory testing. Antimicrobial activity and safety require experimental validation.
Evidence standards
The public research page describes our methods and standards. Candidate inventories, exact sequence-level results and sensitive scientific reports remain in restricted workspaces.
Candidate records and analysis artifacts are versioned and reviewed with attention to reproducibility, data quality and provenance.
Local reference searches help generate hypotheses. Short alignments are not presented as proof of functional homology or peptide novelty.
Antimicrobial efficacy, ecological effects, safety and mechanism of action are not established by computational screening alone.
Historical computational results and newly reproduced local analyses are distinguished. Missing original execution records are not treated as verified.
Research questions
The present research programme evaluates computational candidates. Biological activity, safety and suitability for particular applications must be experimentally tested.
No. An annotated reference organism describes that reference record, not the biological origin of the candidate.
No. Exploratory similarity searches alone do not establish novelty, patentability or freedom to operate.
Yes. We welcome research enquiries. Access to candidate-level evidence, sequences and commercial terms is assessed through controlled partner processes.
Collaborate with BiotaSift
Discuss computational evaluation, research partnerships and responsible biological validation. Candidate access and licensing are assessed individually.
Discuss a collaboration